36 days ago MGC Pharmaceuticals (MXC) drew down A$800,000 of funding from its death spiral provider Mercer. But I guess Christmas is an expensive time for us all, there are bills to pay, yadda, yadda, yadda.
I have warned you for a long time, notably with this dossier HERE, that Standard Listed MGC Pharmaceuticals (MXC) is a dog with fleas drowning in a sea of red flags. Today’s quarterlies, coming after six ramptastic announcements so far this month are piss poor and written with intent to deceive.
Following the publication of my red flag dossier earlier this year, anyone owning shares in MGC Pharmaceuticals (MXC) was fully warned of the need to lube up. I hope they did. The shares were 2.25p back on 11 January when I warned you that this was a £70 million dog from the scholars and gentleman at Turner Pope. They are now just 0.825p but after another red flag admission today they are still a monstrous sell.